SPL 3.00% 9.7¢ starpharma holdings limited

DEP phase 2 trials - patience required!, page-4

  1. 1,802 Posts.
    lightbulb Created with Sketch. 322
    It has been four years since Docetaxel finished it's (very long) phase 1 trial and moved into phase 2. Four years for the phase 2, so far. If they cannot follow a 505B2, how long will a phase 3 take? On drugs that already have FDA approval, albeit some with blackbox warnings. I have friends and colleagues who could benefit from DEP right now.

    Talk about multi- billion dollars deals, and holding on just a little longer make you sound like JF wielding her carrots…
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.